Bionoid Pharma Inc.
BINP
$0.08
$0.000.00%
OTC PK
| 03/31/2012 | 03/31/2011 | ||||
|---|---|---|---|---|---|
| Net Income | -587.60K | -5.68M | |||
| Total Depreciation and Amortization | 7.40K | 8.20K | |||
| Total Amortization of Deferred Charges | -- | -- | |||
| Total Other Non-Cash Items | 574.90K | 4.92M | |||
| Change in Net Operating Assets | 5.90K | 83.10K | |||
| Cash from Operations | 600.00 | -665.00K | |||
| Capital Expenditure | -- | -200.00 | |||
| Sale of Property, Plant, and Equipment | -- | -- | |||
| Cash Acquisitions | -- | -- | |||
| Divestitures | -- | -- | |||
| Other Investing Activities | -- | -- | |||
| Cash from Investing | -- | -200.00 | |||
| Total Debt Issued | -- | -- | |||
| Total Debt Repaid | -- | -20.00K | |||
| Issuance of Common Stock | -- | -- | |||
| Repurchase of Common Stock | -- | -- | |||
| Issuance of Preferred Stock | -- | -- | |||
| Repurchase of Preferred Stock | -- | -- | |||
| Total Dividends Paid | -- | -- | |||
| Other Financing Activities | -- | -- | |||
| Cash from Financing | -- | -20.00K | |||
| Foreign Exchange rate Adjustments | -600.00 | 2.30K | |||
| Miscellaneous Cash Flow Adjustments | -- | -- | |||
| Net Change in Cash | -100.00 | -682.90K | |||